16 December 2024
Coulter Partners places Life Sciences Industry Veteran as CFO at Altimmune
Coulter Partners successfully completed a search assignment for Altimmune and is pleased to announce the placement of Life Sciences Industry Veteran Greg Weaver, MBA, as Chief Financial Officer (CFO).
Altimmune is a clinical-stage biopharmaceutical company focused on developing innovative next-generation peptide-based therapeutics. The Company is developing pemvidutide, a GLP-1/glucagon dual receptor agonist for the treatment of obesity and MASH.
Commenting on the collaboration with Coulter Partners, Vipin K. Garg, Ph.D., President and Chief Executive Officer of Altimmune, said:
“Coulter Partners impressed us with their life sciences expertise, professionalism, and urgency, delivering top candidates and ensuring the best fit. We're pleased to have partnered with them.”
Related
-
Placement News
Top global hires for large-cap, mid-cap and public companies H2-2023
12 December 2023
-
Press Releases
Coulter Partners places former Evotec executives as Chief R&D Officer and SVP Biology, Discovery Strategy group at Dalriada
06 July 2023
-
Placement News
Top hires for VC & PE portfolio companies Q2-2022
14 July 2022
-
Placement News
Coulter Partners secures Chief Medical Officer for Saniona
01 May 2020
